A small human body fluid sample, carefully filtered through a technically precise process, delivers information that can lead to the right decisions. It sounds so simple, but this patented technology holds deep complexity – with applications from medical diagnostics to chemical warfare.
Click here to learn more about the RPS Adeno DetectorTM, the first commercially available product that uses this exciting technology.
RPS currently holds two patents to support this technology. More patents are pending approval. The flexibility of the technology opens new opportunities for diverse uses. In addition to securing government contracts for detecting chemical warfare nerve agents, RPS also seeks to introduce new medical devices to both U.S. and world markets.